Spero Therapeutics, Inc.SPRONASDAQ
Loading
Profit from core business operations before interest and taxes
Percentile
P40
Within normal range
vs 2Y Ago
-2.2x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-46.82M | +36.2% |
| 2024 | $-73.36M | -441.5% |
| 2023 | $21.48M | +150.9% |
| 2022 | $-42.20M | +52.0% |
| 2021 | $-87.97M | -11.2% |
| 2020 | $-79.11M | -25.1% |
| 2019 | $-63.22M | -47.7% |
| 2018 | $-42.81M | -2.6% |
| 2017 | $-41.73M | -25.6% |
| 2016 | $-33.22M | - |